Research on the Mechanisms of Treatment Non-response in Inflammatory Bowel Disease Based on Multi-omics Technology

RecruitingOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

December 1, 2023

Primary Completion Date

December 1, 2024

Study Completion Date

December 1, 2025

Conditions
Inflammatory Bowel Diseases
Interventions
DRUG

biologic therapy(eg:IFX,ADA,UST,VDZ)

The patients received biologic therapy during the baseline period, and the specific type of medication was determined based on the professional doctor's diagnosis and treatment opinions. Patients were then divided into two groups based on whether primary non-response occurred or not.

Trial Locations (1)

510515

RECRUITING

NanFang Hospital of Southern Medical University, Guangzhou

All Listed Sponsors
lead

Nanfang Hospital, Southern Medical University

OTHER